PLx Pharma Shares Rally After FDA Approves Supplemental New Drug Application
PLx Pharma Inc (NASDAQ: PLXP) shares were trading higher Monday after the company announced that the U.S. Food and Drug Administration approved a supplemental new drug application for its lead products Vazalore 325 mg and Vazalore 85 mg, the first novel, liquid-filled aspirin capsule.